Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Chiron confirms discussions.


EMERYVILLE, Calif.--(BUSINESS WIRE)--Nov. 11, 1994--Chiron Corp. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: CHIR CHIR Chiricahua National Monument (US National Park Service) ) confirmed Friday that it is in discussions with another company regarding a potential strategic alliance that would include the other company acquiring a very substantial minority equity investment in Chiron.

Chiron said that no agreement has been reached and that there is no assurance any transaction will result.

Chiron is a biotechnology company headquartered in Emeryville. Chiron is building a healthcare business that addresses needs in several markets: diagnostics, including immunodiagnostics and new quantitative tests based on nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis.  probe technology; adult and pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children.

pe·di·at·ric
adj.
Of or relating to pediatrics.
 vaccines; therapeutics, with an emphasis on oncology, serious infectious diseases and other diseases requiring critical care; and ophthalmology through the surgical correction of vision.

CONTACT: Chiron Corp., Emeryville

Larry Kurtz, 510/601-2476
COPYRIGHT 1994 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 11, 1994
Words:126
Previous Article:New family of 2.5-inch Areal drives offers higher capacities.
Next Article:KLA Instruments receives multiple in-line monitor order from AMD.
Topics:



Related Articles
Chiron and Ciba-Geigy form unique global partnership in biotechnology; Ciba to hold 49.9% interest in Chiron following tender offer for 11.9 million...
Chiron and Genelabs announce worldwide diagnostics alliance.
Chiron announces management changes including appointing Pablo Valenzuela president of Chiron Diagnostics.
CHIRON BIOCINE GENETICALLY ENGINEERED ACELLULAR PERTUSSIS VACCINE PROVES SUPERIOR TO CURRENTLY LICENSED VACCINE.
Chiron and Ciba to Collaborate on Combinatorial Chemistry-Based Research and Development.
Chiron and Green Cross Broaden Clinical Trials of Gene Therapy-Based HIV Immunotherapeutic.
Chiron and Biomira form partnership for THERATOPE cancer vaccine.
Depotech repurchases marketing rights to DepoCyt for Europe and Canada from Chiron.
Chiron Diagnostics Receives 510(k) Clearance for ACS:Centaur Immunoassay System.
THERATOPE Vaccine to Enter Phase III Clinical Trials.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles